Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Nordic Drugs Aktiebolag
AB
Active
Org 5565055141
Södergatan 26, 211 34
Malmö
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1995
25 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Nordic Drugs Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (3)
HM
Henna Mielikki Saarialho-Kahila
Chief Executive Officer
Chief Executive Officer
2025
OC
Ove Christofer Hultén
Chief Auditor
Chief Auditor
2020
ES
Emilie Sofia Nord
Chief Auditor
Chief Auditor
2026
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
CA
Charlotte Anne Phelps
Chairman
2020
AT
Anders Theodor Löfgren
Board of Directors
2020
GJ
Graham James Clark
Board of Directors
2022
Former (2)
ED
Enrique Damian Rodriguez de la Rubia
Board of Directors
2023 – 2023
AE
Arnaud Etienne
Board of Directors
2020 – 2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
NORDIC GROUP BV
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Nordic Drugs Aktiebolag
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network